- Exchange: Xetra
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Bayer AG (BAYN)
| Open: | - | Day's Range: | - | Volume: | 4,518,074 |
|---|---|---|---|---|---|
| Previous Close: | 84.280 | 52wk Range: | 47.625 - 85.670 | 1-Yr Rtn: | +70.62% |
Key Statistics for BAYN
| Current P/E Ratio (ttm) | 27.2751 |
|---|---|
| Estimated P/E(12/2013) | 14.3285 |
| Relative P/E vs. DAX | 1.7302 |
| Earnings Per Share (EUR) (ttm) | 3.0900 |
| Est. EPS (EUR) (12/2013) | 5.8820 |
| Est. PEG Ratio | 1.3793 |
| Market Cap (M EUR) | 69,695.16 |
| Shares Outstanding (M) | 826.95 |
| 30 Day Average Volume | 2,297,049 |
| Price/Book (mrq) | 3.5423 |
| Price/Sale (ttm) | 1.7437 |
| Dividend Indicated Gross Yield | 2.26% |
| Cash Dividend (EUR) | 1.9000 |
| Last Dividend | 04/29/2013 |
| 5 Year Dividend Growth | 7.07% |
| Next Earnings Announcement | 07/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BAYN
Company Profile & Key Executives for BAYN
Bayer AG produces and markets healthcare and agricultural products, and polymers. The Company manufactures products that include aspirin, antibiotics, anti-infectives, and cardiovascular, oncology, and central nervous system drugs, over-the-counter medications, diagnostics, animal health products, crop protection products, plastics, and polyurethanes.
| Marijn E DekkersChairman-Mgmt Board/CEO | Werner BaumannCFO/Member-Mgmt Board |
| Wolfgang PlischkeCTO/Member-Mgmt Board | Richard PottChief Strategy & Human Resource |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BAYN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page